Soluble ST2 protein in chronic heart failure is independent of traditional factors.

Arch Med Sci 2013 Feb;9(1):21-6

Department of Cardiology, Medical University of Lodz, Poland.

Introduction: ST2 protein is the interleukin 33 (IL-33) receptor, whose serum level depends on the biomechanical strain of cardiac myocytes. The aim of this study was to analyse the relationship between soluble ST2 (sST2) level and traditional factors in patients with chronic heart failure.

Material And Methods: Sixty-six patients (mean age 62 years, 75% males) in stable NYHA class I-III with left ventricular ejection fraction < 45% were included in the study. Clinical, biochemical, electrocardiographic, echocardiographic and angiographic data were analysed. Patients were divided into groups depending on sST2 median: > 0.28 ng/ml (n = 31) vs. ≤ 0.28 ng/ml (n = 35). sST2 was measured using a quantitative ELISA kit. In order to define factors associated with sST2 levels uni- and multivariate regression analysis was performed.

Results: There was no relationship between sST2 levels and age (p = 0.67), body mass index (p = 0.19), hsTnT (p = 0.7) or other analysed parameters (all p > 0.05), except for N-terminal prohormone B-type natriuretic peptide (NT-proBNP). A significant positive correlation between sST2 and NT-proBNP was found (p = 0.013, R = 0.395). Multivariate analysis revealed that the stage of coronary artery disease and NT-proBNP were independent factors associated with sST2 concentration (p = 0.04). Intriguing is the fact that the fewer the sclerotic changes present in arteries, the higher was the sST2 level (β = -0.381, p = 0.04).

Conclusions: sST2 protein is independent of traditional factors which usually affect levels of NT-proBNP. In chronic heart failure, sST2 protein may be of greater importance in idiopathic dilated cardiomyopathy than in ischaemic aetiology, which seems to be associated with the molecular mechanism (biomechanical strain) related to sST2.

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2013.33344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598130PMC
February 2013

Publication Analysis

Top Keywords

chronic heart
12
traditional factors
12
sst2
11
heart failure
8
associated sst2
8
factors associated
8
independent traditional
8
sst2 levels
8
biomechanical strain
8
soluble st2
8
sst2 protein
8
st2 protein
8
sst2 level
8
028 ng/ml
8
factors
5
sst2 measured
4
levels uni-
4
sclerotic changes
4
ng/ml sst2
4
ng/ml ≤
4

Similar Publications

Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.

Kardiol Pol 2014 20;72(8):725-34. Epub 2014 May 20.

Klinika Kardiologii, Uniwersytet Medyczny w Łodzi, Łódź.

Background: The prognosis in patients with chronic heart failure (CHF) is poor. ST2 protein is a promising prognostic biomarker for CHF. ST2 belongs to the cardioprotective signalling pathway involving interleukin-33 and its concentration in the serum depends on the biomechanical stress of cardiomyocytes (biomechanical strain). Read More

View Article and Full-Text PDF
December 2016

Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.

Eur J Heart Fail 2020 11 9;22(11):2078-2088. Epub 2020 Jan 9.

Fondazione Toscana G. Monasterio, Pisa, Italy.

Aims: N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hs-TnT) and soluble suppression of tumorigenesis-2 (sST2) predict outcome in chronic heart failure (HF). We assessed the influence of age on circulating levels and prognostic significance of these biomarkers.

Methods And Results: Individual data from 5301 patients with chronic HF and NT-proBNP, hs-TnT, and sST2 data were evaluated. Read More

View Article and Full-Text PDF
November 2020

[Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].

Kardiologiia 2017 Jan(1):48-58

Institute of Cardiology of Russian Cardiology Scientific and Production Complex, Moscow, Russia.

Purpose: to evaluate the significance of soluble ST2-receptor (sST2) concentrations in patient (pts) risk stratification in with acute decompensated heart failure (ADHF) during long-term follow-up period.

Methods: In the prospective single-center study were included 159 pts with ADHF III-IV FC NYHA. Blood samples to determine NT-proBNP, sST2, hsTnT concentration were collected at the admission and at discharge from the hospital, and after 3, 6 and 12 months of follow-up. Read More

View Article and Full-Text PDF
January 2017

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.

Circulation 2008 Apr 31;117(15):1936-44. Epub 2008 Mar 31.

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

Background: ST2 is a member of the interleukin-1 receptor family with a soluble form that is markedly upregulated on application of biomechanical strain to cardiac myocytes. Circulating ST2 levels are elevated in the setting of acute myocardial infarction, but the predictive value of ST2 independent of traditional clinical factors and of an established biomarker of biomechanical strain, N-terminal prohormone B-type natriuretic peptide (NT-proBNP), has not been established.

Methods And Results: We measured ST2 at baseline in 1239 patients with ST-elevation myocardial infarction from the CLopidogrel as Adjunctive ReperfusIon TherapY-Thrombolysis in Myocardial Infarction 28 (CLARITY-TIMI 28) trial. Read More

View Article and Full-Text PDF
April 2008